The NAFLD liver fat score (NLFS) incorporates metabolic syndrome, type 2 diabetes status, fasting insulin level, and fasting aspartate aminotransferase/alanine aminotransferase ratio, and has an 86% sensitivity in detecting NAFLD (Kotronen et al., 2009). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.